Publications by authors named "Srinivas Devarakonda"

Claim this Profile
C
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era.
Megan Broughton, Subodh Bhatta, Doshi Sonali, Naresh Bumma, Abdullah M Khan, Srinivas Devarakonda

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab.
Charles Pei, Zeinab El Boghdadly, Lisa Blackburn, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Srinivas Devarakonda

J Natl Compr Canc Netw· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.
Elvira Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao, Nidhi Sharma, Srinivas Devarakonda

J Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.
Nina Rosa Neuendorff, Abdullah Khan, Fabian Ullrich, Samuel Yates, Srinivas Devarakonda

J Geriatr Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Srinivas Devarakonda

J Natl Compr Canc Netw· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma.
Abdullah M Khan, Kiatlyn Dvorak, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Srinivas Devarakonda

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Srinivas Devarakonda

J Natl Compr Canc Netw· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m versus 200mg/m preparative regimens in patients with multiple myeloma.
Nidhi Sharma, Evan Benson, Qiuhong Zhao, Jordan Nunnelee, Francesca Cottini, Srinivas Devarakonda

Leuk Lymphoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma.
Alicia Bao, Qiuhong Zhao, Ruchi Kudalkar, Jose Rodriguez, Nidhi Sharma, Srinivas S Devarakonda

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.
Abdullah M Khan, Michael Ozga, Harshil Bhatt, Muhammad S Faisal, Sadia Ansari, Srinivas Devarakonda

Clin Lymphoma Myeloma Leuk· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Abdullah M Khan, Filiz Yucebay, Qiuhong Zhao, Elvira Umyarova, Francesca Cottini, Srinivas Devarakonda

Clin Lymphoma Myeloma Leuk· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Srinivas Devarakonda

J Natl Compr Canc Netw· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first relapse in multiple myeloma: how to pick the next best thing.
Srinivas Devarakonda, Nidhi Sharma, Yvonne Efebera

Hematology Am Soc Hematol Educ Program· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma.
Jordan Nunnelee, Francesca Cottini, Qiuhong Zhao, Muhammad Salman Faisal, Patrick Elder, Srinivas Devarakonda

J Clin Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences as predictors of outcomes in young patients with multiple myeloma.
Alicia Bao, Qiuhong Zhao, Elizabeth Merritt, Naresh Bumma, Srinivas Devarakonda

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience.
Jordan Nunnelee, Francesca Cottini, Qiuhong Zhao, Muhammad Salman Faisal, Patrick Elder, Srinivas Devarakonda

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
Zachary Braunstein, Eric McLaughlin, Miguel Ruiz, Lai Wei, Naresh Bumma, Srinivas Devarakonda

Front Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant.
Audrey M Sigmund, Qiuhong Zhao, Justin Jiang, Patrick Elder, Don M Benson, Srinivas Devarakonda

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, Larry D Anderson, Erica Campagnaro, Srinivas Devarakonda

J Natl Compr Canc Netw· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation.
Nidhi Sharma, Muhammad Salman Faisal, Qiuhong Zhao, Justin Jiang, Patrick Elder, Srinivas Devarakonda

J Clin Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
Michael Ozga, Qiuhong Zhao, Don Benson, Patrick Elder, Nita Williams, Srinivas Devarakonda

Cancer Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation.
Nidhi Sharma, Qiuhong Zhao, Bin Ni, Patrick Elder, Marcin Puto, Srinivas Devarakonda

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients.
Francesca Cottini, Ying Huang, Nita Williams, Naresh Bumma, Abdullah M Khan, Srinivas Devarakonda

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Stem Cell Transplantation in Multiple Myeloma.
Srinivas Devarakonda, Yvonne Efebera, Nidhi Sharma

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis